Mauna Kea Technologies

Report Publication Announcement • Jan 15, 2020

Mauna Kea Technologies Announces its 2020 Financial Calendar

Paris and Boston, January 15, 2020 – 5.45 PM CET – Mauna Kea Technologies(Euronext: MKEA,) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced the publication of its 2020 Financial Calendar.

Event	Date*
2019 Fourth-Quarter and Full-Year Sales	January 29, 2020
2019 Full-Year Financial Results	March 25, 2020
2020 First-Quarter Sales	April 20, 2020
2020 Second-Quarter and First-Half Sales	July 20, 2020
2020 First-Half Financial Results	September 22, 2020
2020 Third-Quarter Sales	October 19, 2020

* Subject to modification. Press releases are published after market closes.

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio®, has received clearance/approval in a wide range of applications in more than 40 countries, including the United States, Europe, Japan, and China. For more information on Mauna Kea Technologies, visit www.maunakeatech.com

United States	France and Europe
Mike Piccinino, CFA	NewCap - Investor Relations
Westwicke, an ICR Company	Alexia Faure
443-213-0500	+33 (0)1 44 71 94 94
	maunakea@newcap.eu

Disclaimer

This press release contains forward-looking statements concerning Mauna Kea Technologies and its activities. Such forward looking statements are based on assumptions that Mauna Kea Technologies considers to be reasonable. However, there can be no assurance that the anticipated events contained in such forward-looking statements will occur. Forward- looking statements are subject to numerous risks and uncertainties including the risks set forth in the registration document of Mauna Kea Technologies registered by the French Financial Markets Authority (Autorité des marchés financiers (AMF)) on July 12, 2019 under number R.19-0683 and available on the Company's website (www.maunakeatech.com), and to the development of economic situation, financial markets, and the markets in which Mauna Kea Technologies operates. The forward-looking statements contained in this release are also subject to risks unknown to Mauna Kea Technologies or that Mauna Kea Technologies does not consider material at this time. The realization of all or part of these risks could lead to actual results, financial conditions, performances or achievements by Mauna Kea Technologies that differ significantly from the results, financial conditions,

performances or achievements expressed in such forward-looking statements. This press release and the information it contains do not constitute an offer to sell or to subscribe for, or a solicitation of an order to purchase or subscribe for, Mauna Kea Technologies shares in any country.